Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
Title : Variants of carboxylesterase 1 have no impact on capecitabine pharmacokinetics and toxicity in capecitabine plus oxaliplatin treated-colorectal cancer patients - Matsumoto_2020_Cancer.Chemother.Pharmacol__ |
Author(s) : Matsumoto N , Kubota Y , Ishida H , Sekido M , Ohkuma R , Ishiguro T , Hirasawa Y , Ariizumi H , Tsunoda T , Ikusue T , Kobayashi K , Hisamatsu A , Toshima H , Shimada K , Fujita KI |
Ref : Cancer Chemother Pharmacol , : , 2020 |
Abstract : Matsumoto_2020_Cancer.Chemother.Pharmacol__ |
ESTHER : Matsumoto_2020_Cancer.Chemother.Pharmacol__ |
PubMedSearch : Matsumoto_2020_Cancer.Chemother.Pharmacol__ |
PubMedID: 32458030 |
Title : 123I-iomazenil whole-body imaging to detect hepatic carboxylesterase drug-metabolizing enzyme activity - Mizutani_2018_Nucl.Med.Commun_39_825 |
Author(s) : Mizutani A , Kobayashi M , Fujita KI , Takahashi K , Hokama T , Takasu H , Nishi K , Nishii R , Shikano N , Fukuchi K , Kawai K |
Ref : Nucl Med Commun , 39 :825 , 2018 |
Abstract : Mizutani_2018_Nucl.Med.Commun_39_825 |
ESTHER : Mizutani_2018_Nucl.Med.Commun_39_825 |
PubMedSearch : Mizutani_2018_Nucl.Med.Commun_39_825 |
PubMedID: 29877992 |